Dr. Peter Light is the ADI Director, the Dr. Charles A. Allard Chair in Diabetes Research, Professor of Pharmacology, University of Alberta and Board Director of the Canadian Diabetes Association
UPCOMING SEMINARS
LATEST NEWS AND PUBLICATIONS.....
Common KATP channel diabetes risk variants change MgATPase activity and pharmacology: See our latest Diabetes paper here! and our latest Pharmacogenetics and Genomics paper here!
Can KATP modulating drugs be used to treat arrhythmias? See our latest Current Medicinal Chemistry Review here!
The Light lab currently has several vacancies for highly motivated graduate students and post docs.
IsletCore
celebrates one year in operation!
The ADI Clinical Research Unit has opened it's doors and accepting trials.
RESEARCH OVERVIEW.....
The research laboratory of Dr. Peter Light studies ion transport processes controlling cellular excitability. We utilize a combination of electrophysiological, biochemical and molecular techniques to study the physiology and pharmacology of ion channels and exchangers at the molecular, cellular, organ and whole organism levels.
Currently, we are studying the following:
1. The ionic and metabolic events that lead to
cellular dysfunction
in the heart
and endocrine pancreas
2. Common gene variants in ion channels and
susceptibility to
type 2 diabetes.
3.
Ion transport pharmacology and pharmacogenomics
4. Molecular engineering of islets to improve
post-transplant function and survival
Go to the the research page
for details of our latest research, papers and
trainee opportunities
